1. Case Report: Refractory Autoimmune Gastritis Responsive to Abatacept in LRBA Deficiency
- Author
-
Valentina Boz, Erica Valencic, Martina Girardelli, Alessia Pin, Laura Gàmez-Diaz, Alberto Tommasini, Sara Lega, Matteo Bramuzzo, Boz, V., Valencic, E., Girardelli, M., Pin, A., Gamez-Diaz, L., Tommasini, A., Lega, S., and Bramuzzo, M.
- Subjects
lcsh:Immunologic diseases. Allergy ,abatacept ,lymphoproliferation ,autoimmune gastritis ,case report ,inflammatory bowel disease ,LRBA deficiency ,primary immumunodeficiencies ,Autoimmune Gastritis ,Immunology ,medicine.disease_cause ,Inflammatory bowel disease ,Autoimmunity ,LRBA ,Immune system ,medicine ,Immunology and Allergy ,autoimmune gastriti ,business.industry ,Abatacept ,Immune dysregulation ,medicine.disease ,Primary immunodeficiency ,lcsh:RC581-607 ,business ,medicine.drug - Abstract
Primary immunodeficiency (PID) with immune dysregulation may present with early onset gastrointestinal autoimmune disorders. When gastrointestinal autoimmunity is associated with multiple extraintestinal immune system dysfunction the diagnosis of PID is straightforward. However, with the advent of next generation sequencing technologies, genetic defects in PID genes have been increasingly recognized even when a single or no extraintestinal signs of immune dysregulation are present. A genetic diagnosis is especially important considering the expanding armamentarium of therapies designed to inhibit specific molecular pathways. We describe a boy with early-onset severe, refractory autoimmune gastritis and biallelic mutations in the LRBA gene causing a premature STOP-codon who was successfully treated with CTLA4-Ig, abatacept, with long term clinical and endoscopic remission. The case underscores the importance to consider a monogenetic defect in early onset autoimmune disorders, since the availability of targeted treatments may significantly improve patient prognosis.
- Published
- 2021
- Full Text
- View/download PDF